跳转至内容
Merck
所有图片(1)

文件

MAB846

Sigma-Aldrich

Anti-Mumps Blend Antibody, fusion protein, clones 570-7A, 570-12G

Chemicon®, from mouse

登录查看公司和协议定价


About This Item

分類程式碼代碼:
12352203
eCl@ss:
32160702
NACRES:
NA.41

生物源

mouse

品質等級

抗體表格

purified antibody

抗體產品種類

primary antibodies

無性繁殖

570-12G, monoclonal
570-7A, monoclonal

物種活性

human

製造商/商標名

Chemicon®

技術

ELISA: suitable
immunofluorescence: suitable
western blot: suitable

同型

IgG

運輸包裝

wet ice

特異性

Specific for mumps and has shown reactivity to the mumps ENDERS strain.

免疫原

Epitope: fusion protein

應用

Anti-Mumps Blend Antibody, fusion protein, clones 570-7A, 570-12G is an antibody against Mumps Blend for use in ELISA, IF & WB.
EIA at 1:1,000 - 3,000.

Immunofluorescence at 1:1,000 - 3,000.

Final working dilutions must be determined by end user.
Research Category
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral

外觀

Format: Purified
In 0.02M phosphate buffer, 0.25 NaCl with 0.1% sodium azide.

儲存和穩定性

Maintain at +2-8°C for up to 12 months.

其他說明

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

法律資訊

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

免責聲明

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our 产品选型工具.

儲存類別代碼

10 - Combustible liquids

水污染物質分類(WGK)

WGK 2

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

T Vermeire et al.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 25(7), 907-907 (2018-12-07)
Mumps used to affect children between 2 and 15 years old. The mumps-measles-rubella (MMR) vaccine is available, with vaccine coverage rate of about 85% after two vaccine doses. Recently new mumps outbreaks have emerged in highly vaccinated populations; the causes for
Mumps and diabetes.
W P D LOGAN
Monthly bulletin of the Ministry of Health and the Public Health Laboratory Service null
Stephanie Franz et al.
Journal of virology, 91(18) (2017-07-01)
The mumps virus (MuV) small hydrophobic protein (SH) is a type I membrane protein expressed in infected cells. SH has been reported to interfere with innate immunity by inhibiting tumor necrosis factor alpha (TNF-α)-mediated apoptosis and NF-κB activation. To elucidate
J S Ellis et al.
Journal of clinical microbiology, 35(8), 2076-2082 (1997-08-01)
Multiple-target (multiplex) reverse transcription-PCR (RT-PCR) for detection, typing, and subtyping of the hemagglutinin gene of influenza type A (H3N2 and H1N1) and type B viruses was developed and applied prospectively to virological surveillance of influenza in England in the 1995-1996

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门